Literature DB >> 29316997

Results of balloon pulmonary valvoplasty in children with Noonan's syndrome.

Jonathon Holzmann1, Shane M Tibby2, Eric Rosenthal1, Shakeel Qureshi1, Gareth Morgan1, Thomas Krasemann1.   

Abstract

Pulmonary valve stenosis is common in patients with Noonan's syndrome. The response to balloon valvoplasty varies.We assessed the correlation between re-intervention rate, immediate response, and the progress of the valve gradient over time after intervention.
METHODS: This is a retrospective study conducted from 1995 to 2014.
RESULTS: Of 14 patients identified, seven had re-intervention 28±54 months (range 3-149, median 3.3) after valvoplasty. These patients did not have a significant decrease in gradient after intervention. Their gradient subsequently decreased during follow-up and then became static before increasing years after intervention. In contrast, the gradient of patients not requiring further intervention continually reduced over time. Demographics did not differ between these groups.
CONCLUSION: We could not identify predisposing factors for long-term success of pulmonary valvoplasty in Noonan's patients, but the trajectory of gradients differs significantly between patients needing re-intervention from those who remain free from re-intervention.

Entities:  

Keywords:  Noonan’s syndrome; Pulmonary stenosis; valvoplasty

Mesh:

Year:  2018        PMID: 29316997     DOI: 10.1017/S1047951117002827

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  2 in total

1.  Congenital heart defects in Noonan syndrome: Diagnosis, management, and treatment.

Authors:  Léa Linglart; Bruce D Gelb
Journal:  Am J Med Genet C Semin Med Genet       Date:  2020-02-05       Impact factor: 3.908

2.  Cardiovascular Abnormalities and Gene Mutations in Children With Noonan Syndrome.

Authors:  Ling Sun; Yu-Mei Xie; Shu-Shui Wang; Zhi-Wei Zhang
Journal:  Front Genet       Date:  2022-06-13       Impact factor: 4.772

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.